LRMR
#3050
Larimar Therapeutics, Inc. - Common Stock
4.0 1 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.99%
Changement Mensuel
+4.97%
Evolution sur 6 mois
-20.28%
Changement Annuel
+9.56%
Clôture Précédente
4.0 5
Open
4.0 1
Low
4.0 1
High
4.0 1
Volume
47
Financials
- Market Capitalization 416.57 M
- Employee 71
- Founded 2005
- CEO N/A
- Website www.larimartx.com
- Headquarter Delaware, United States
- FIGI BBG001J2NVH0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3029 |  BNTC Benitec Biopharma Inc. - Common Stock | 12.47 USD | -1.58% | -7.83% | +5.32% | -24.92% | 428.40 M USD | ||
| 3035 |  RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.86 USD | +6.63% | +9.35% | +21.00% | +18.04% | 423.73 M USD | ||
| 3069 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.02 USD | -2.90% | +9.24% | +23.31% | -6.07% | 405.42 M USD | ||
| 3076 |  XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.04 USD | -4.49% | +0.25% | +1.00% | +36.03% | 400.55 M USD |